Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA.
Heger JM, Mattlener J, Schneider J, Gödel P, Sieg N, Ullrich F, Lewis R, Bucaciuc-Mracica T, Schwarz RF, Rueß D, Ruge MI, Montesinos-Rongen M, Deckert M, Blau T, Kutsch N, Balke-Want H, Weiss J, Becker K, Reinhardt HC, Hallek M, Borchmann P, von Tresckow B, Borchmann S. Heger JM, et al. Among authors: borchmann s. Blood. 2024 Feb 8;143(6):522-534. doi: 10.1182/blood.2023022020. Blood. 2024. PMID: 37946299
Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.
Böll B, Goergen H, Behringer K, Bröckelmann PJ, Hitz F, Kerkhoff A, Greil R, von Tresckow B, Eichenauer DA, Bürkle C, Borchmann S, Fuchs M, Diehl V, Engert A, Borchmann P. Böll B, et al. Among authors: borchmann s, borchmann p. Blood. 2016 May 5;127(18):2189-92. doi: 10.1182/blood-2015-11-681064. Epub 2016 Feb 1. Blood. 2016. PMID: 26834240 Free article. Clinical Trial.
Novel agents in classical Hodgkin lymphoma.
Borchmann S, von Tresckow B. Borchmann S, et al. Leuk Lymphoma. 2017 Oct;58(10):2275-2286. doi: 10.1080/10428194.2017.1300898. Epub 2017 Mar 20. Leuk Lymphoma. 2017. PMID: 28318345
Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1.
Reinke S, Bröckelmann PJ, Iaccarino I, Garcia-Marquez M, Borchmann S, Jochims F, Kotrova M, Pal K, Brüggemann M, Hartmann E, Sasse S, Kobe C, Mathas S, Soekler M, Keller U, Bormann M, Zimmermann A, Richter J, Fuchs M, von Tresckow B, Borchmann P, Schlößer H, von Bergwelt-Baildon M, Rosenwald A, Engert A, Klapper W. Reinke S, et al. Among authors: borchmann s, borchmann p. Blood. 2020 Dec 17;136(25):2851-2863. doi: 10.1182/blood.2020008553. Blood. 2020. PMID: 33113552 Free article. Clinical Trial.
In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin's lymphoma and facilitates ultrasensitive residual disease detection.
Sobesky S, Mammadova L, Cirillo M, Drees EEE, Mattlener J, Dörr H, Altmüller J, Shi Z, Bröckelmann PJ, Weiss J, Kreissl S, Sasse S, Ullrich RT, Reinke S, Klapper W, Gerhard-Hartmann E, Rosenwald A, Roemer MGM, Nürnberg P, Hagenbeek A, Zijlstra JM, Pegtel DM, Engert A, Borchmann P, von Tresckow B, Borchmann S. Sobesky S, et al. Among authors: borchmann s, borchmann p. Med. 2021 Oct 8;2(10):1171-1193.e11. doi: 10.1016/j.medj.2021.09.002. Med. 2021. PMID: 35590205 Free article.
JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO).
Gillessen S, Pluetschow A, Vucinic V, Ostermann H, Kobe C, Bröckelmann PJ, Böll B, Eichenauer DA, Heger JM, Borchmann S, Fuchs M, Borchmann P, Engert A, von Tresckow B. Gillessen S, et al. Among authors: borchmann s, borchmann p. Eur J Haematol. 2022 Dec;109(6):728-735. doi: 10.1111/ejh.13859. Epub 2022 Oct 3. Eur J Haematol. 2022. PMID: 36056778 Clinical Trial.
Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma Niche.
Bröckelmann PJ, Borchmann S, Borchmann P, Engert A. Bröckelmann PJ, et al. Among authors: borchmann s, borchmann p. J Clin Oncol. 2020 Nov 10;38(32):3816-3818. doi: 10.1200/JCO.20.02351. Epub 2020 Sep 18. J Clin Oncol. 2020. PMID: 32946351 No abstract available.
54 results